Home > Balance Sheet > AUROBINDO PHARMA

AUROBINDO PHARMA
Total Non-Current Liabilities

    Back to Balance Sheet
AUROBINDO PHARMA is part of below Screeners ↓
Top Mid Cap Stocks with Best Fundamentals
Best Quarterly Growth Mid Cap Stocks
COMMUNITY POLL
for AUROBINDO PHARMA
Please provide your vote to see the results

AUROBINDO PHARMA Last 5 Year Total Non-Current Liabilities History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
Total Non-Current Liabilities ₹1,809 Cr₹867 Cr₹903 Cr₹807 Cr₹555 Cr

What is the latest Total Non-Current Liabilities ratio of AUROBINDO PHARMA ?

The latest Total Non-Current Liabilities ratio of AUROBINDO PHARMA is ₹1,809 Cr based on Mar2024 Consolidated results.
Year Total Non-Current Liabilities
Mar2024₹1,809 Cr
Mar2023₹867 Cr
Mar2022₹903 Cr
Mar2021₹807 Cr
Mar2020₹555 Cr

How is Total Non-Current Liabilities of AUROBINDO PHARMA Trending?

Years Total Non-Current Liabilities % Change
Mar2024 ₹1,809 Cr
108.67
Mar2023 ₹867 Cr
-4.01
Mar2022 ₹903 Cr
11.87
Mar2021 ₹807 Cr
45.43
Mar2020 ₹555 Cr -

Compare Total Non-Current Liabilities of peers of AUROBINDO PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
AUROBINDO PHARMA ₹63,667.3 Cr -4.2% -7.8% -12.7% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹399,249.0 Cr -1.3% -3.3% 8.3% Stock Analytics
DIVIS LABORATORIES ₹174,940.0 Cr -1.5% 0.8% 42.3% Stock Analytics
CIPLA ₹121,197.0 Cr -1.7% 2.3% -5.8% Stock Analytics
DR REDDYS LABORATORIES ₹110,618.0 Cr -1.6% 8.4% 10.6% Stock Analytics
TORRENT PHARMACEUTICALS ₹107,250.0 Cr -3.3% -1.4% 9.8% Stock Analytics


AUROBINDO PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
AUROBINDO PHARMA

-4.2%

-7.8%

-12.7%

SENSEX

1.6%

1%

7%


You may also like the below Video Courses